Sartorius Stedim Biotech Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	203.9	426.1	678.9	116.6	107.1	223.6
Cash & Short-Term Investments	203.9	426.1	678.9	116.6	107.1	223.6
Cash Growth	-70.84%	-37.24%	482.25%	8.87%	-52.10%	274.15%
Accounts Receivable	273.2	192.8	265.9	293.7	404.6	356
Inventory	714.3	690.9	684.9	882.4	1,025	783
Other Current Assets	161.3	131.4	111.3	122.4	134.8	93
Total Current Assets	1,353	1,441	1,741	1,415	1,671	1,456
Net Property, Plant & Equipment	2,064	2,025	1,885	1,633	1,292	928.4
Other Intangible Assets	1,500	1,537	1,632	1,693	876.8	684.4
Goodwill	2,894	2,884	2,908	2,885	1,136	820.7
Long-Term Investments	20.9	19	24	40.8	24.9	14.8
Other Long-Term Assets	85.7	78.8	66.5	62.6	64.1	47.2
Total Assets	7,918	7,984	8,256	7,730	5,065	3,951
Accounts Payable	288.8	277.8	310	258.5	485.6	471.2
Accrued Expenses	90.5	99.1	88.2	62.3	74.1	97.2
Current Portion of Long-Term Debt	289.9	557.3	39.5	57.7	4.5	25.5
Current Portion of Leases	24.9	23.4	25	21.4	19.5	14.9
Unearned Revenue	182.8	167.6	216.1	238.6	-	-
Other Current Liabilities	289.4	287	260.1	298.8	452.1	428.3
Total Current Liabilities	1,166	1,412	938.8	937.3	1,036	1,037
Long-Term Debt	1,942	1,867	2,684	3,510	1,021	521.1
Long-Term Leases	146.1	151.2	120.6	93.1	91.1	64
Other Long-Term Liabilities	416.5	427.2	488.8	516.2	403.5	595.7
Total Long-Term Liabilities	2,504	2,446	3,294	4,119	1,515	1,181
Total Liabilities	3,671	3,858	4,233	5,056	2,551	2,218
Common Stock	19.5	19.5	19.5	18.4	18.4	18.4
Additional Paid-in Capital	1,424	1,424	1,424	231.5	231.5	231.5
Retained Earnings	2,793	2,647	2,543	2,389	2,199	1,406
Total Common Shareholders' Equity	4,237	4,091	3,987	2,639	2,449	1,656
Minority Interest	10	35.6	37.2	35.3	64.9	77.4
Shareholders' Equity	4,247	4,126	4,024	2,674	2,514	1,733
Total Liabilities & Equity	7,918	7,984	8,256	7,730	5,065	3,951
Total Debt	2,403	2,599	2,870	3,682	1,136	625.5
Net Cash (Debt)	-2,199	-2,173	-2,191	-3,565	-1,029	-401.9
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-22.69	-22.34	-22.64	-38.69	-11.16	-4.36
Book Value	4,237	4,091	3,987	2,639	2,449	1,656
Book Value Per Share	43.73	42.04	41.19	28.63	26.58	17.96
Tangible Book Value	-157.2	-330	-553	-1,940	436.1	150.8
Tangible Book Value Per Share	-1.62	-3.39	-5.71	-21.05	4.73	1.64